Michael Bartholomew

Michael Bartholomew has worked in various roles since 1991. Michael began their career at Pfizer as a Senior Sales Leader, a role they held for 15 years. In 2006, they moved to Dohmen Life Science Services as Vice President of Sales and Marketing, a role they held for four years. In 2010, they became Vice President of Global Commercialization at Porzio Life Sciences, LLC. In 2016, they became EVP & Co-Founder, Inside Director BoD at Promaxo. In 2018, they joined Otomagnetics, Inc. as a Member of the Board of Advisors. In 2019, they became Outside Director, Board of Directors at Achelios Therapeutics, Advisor at Navaux, Advisor at 8chili, and Founding Investor at KYTO Technology & Life Science, Inc. Michael is currently Co-Founder and Advisor to BoD at neuro42.

Michael Bartholomew graduated from Bloomington High School North with a High School Diploma with High Distinction. Michael then attended Indiana University Bloomington, where they earned a BA & BS in Honors Economics & Applied Math with Distinction. Afterwards, they completed a Master's of Science in Administration with Highest Distinction from Central Michigan University, specializing in Health Services Administration.